Published in
Public Library of Science, PLoS ONE, 9(10), p. e0138847, 2015
DOI: 10.1371/journal.pone.0138847
Links
- ORCID
- ORCID
- Public Library of Science
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [serval.unil.ch] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [dash.harvard.edu] | PDF
- [serval.unil.ch] | PDF
Tools
Connexin43 Inhibition Prevents Human Vein Grafts Intimal Hyperplasia
,
Florent Allagnat ,
Florian Alonso,
Christopher Kuppler,
Céline Dubuis,
Charles-Keith Ozaki,
Scott Berceli ,
Sebastien Deglise,
James R. Mitchell,
Jean-Marc Corpataux,
Sébastien Déglise,
Jacques-Antoine Haefliger
Full text: Download
Abstract
Venous bypass grafts often fail following arterial implantation due to excessive smooth muscle cells (VSMC) proliferation and consequent intimal hyperplasia (IH). Intercellular communication mediated by Connexins (Cx) regulates differentiation, growth and proliferation in various cell types. Microarray analysis of vein grafts in a model of bilateral rabbit jugular vein graft revealed Cx43 as an early upregulated gene. Additional experiments conducted using an ex-vivo human saphenous veins perfusion system (EVPS) confirmed that Cx43 was rapidly increased in human veins subjected ex-vivo to arterial hemodynamics. Cx43 knock-down by RNA interference, or adenoviral-mediated overexpression, respectively inhibited or stimulated the proliferation of primary human VSMC in vitro. Furthermore, Cx blockade with carbenoxolone or the specific Cx43 inhibitory peptide 43gap26 prevented the burst in myointimal proliferation and IH formation in human saphenous veins. Our data demonstrated that Cx43 controls proliferation and the formation of IH after arterial engraftment.